Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.
Hello,
Today in healthcare news: a breakdown of how the top coronavirus vaccines work, a closer look at Clover Health’s financial performance over the years, and the top investors in digital health.
The US is betting on 3 types of coronavirus vaccines, one of which is totally unproven. A diagram shows how they differ.
- The Trump administration is backing six coronavirus vaccine candidates as part of Operation Warp Speed.
- Each vaccine targets the virus’ spike protein, which helps it attach to and invade cells. But they use three different technological approaches in order to do that.
- The leading two candidates, from Moderna and Pfizer, are mRNA vaccines. The others are protein-based or viral vector vaccines. The chart below shows the difference.
Check out the diagram from Aria Bendix here>>
Clover Health is going public. Here's an inside look at its enrollment and financial performance over the past 5 years.
- The Social Capital SPAC led by billionaire Chamath Palihapitiya is acquiring Clover Health in a $3.7 billion deal that'll take the health insurance company public.
- Clover offers health plans to seniors 65 and up through Medicare Advantage, the private arm of the federally funded Medicare program.
- Here's a look at Clover's enrollment and financial performance from 2015 to 2020.
Investors just poured $8.4 billion into startups in the hottest part of healthcare. Here are the 5 top VC firms making the most digital-health bets.
- Private investment in healthcare startups remained strong in the third quarter of 2020, according to a new CB Insights report out Monday.
- Private investors across the world invested $21.8 billion in healthcare startups, smashing the previous record of $18.1 billion set just the previous quarter.
- Digital health startups remained the most popular investment within healthcare in the quarter, according to the report, and saw an all-time-high $8.4 billion in private investment.
Read the full story by Megan Hernbroth here>>
More stories we're reading:
- CVS is hiring 15,000 new staff to cope with an expected rise of COVID-19 cases and the potential rollout of a vaccine (Business Insider)
- Alphabet's longevity bet Calico has started its first clinical trial, and it's for a cancer drug (Endpoints)
- Biotechs are packing multiple founding rounds into a single year (Stat News)
- Meet the 11 companies racing to make a COVID-19 test that's as quick and easy to take as a pregnancy test (Business Insider)
Know someone who might enjoy this daily newsletter? Tell them to subscribe here!
- Lydia
Read the original article on Business Insider